Movement Alert|Molina Healthcare Rises 5.03% in Regular Trading, RBC Initiation and Illinois Contract Win Continue to Boost Sentiment

Market Focus06-27 01:51

On June 26, Molina Healthcare rose 5.03% in regular trading, trading at $226.83/share, with turnover of $148 million. The stock extended gains following a series of positive catalysts including RBC Capital's initiation of coverage and the company's Illinois Medicaid contract win.

RBC Capital initiated coverage on June 23 with a Sector Perform rating and a $216 price target, citing a clear path to earnings growth through 2027 driven by the reversal of Florida CMS startup costs, the exit from Medicare Advantage Prescription Drug plans, and operating leverage from approximately $6 billion in new revenue. RBC's adjusted EPS estimate for 2027 stands at $9.60, broadly in line with management's outlook of at least $4.50 per share in embedded earnings.

Additionally, Molina recently won an Illinois Medicaid managed care contract covering approximately 3.1 million beneficiaries, effective January 2027 for four-and-a-half years with extension options. Multiple investment banks have also raised price targets, with UBS adjusting to $202 and Truist to $205, reflecting improving industry sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment